Our team is eagerly awaiting to meet-up with you at Booth no.538 to share how our latest services and models can help bring your research programs a step further.
Poster #50:Bidan N. et al., Development of paired enfortumab vedotin-resistant urothelial cancer models using organoid and PDX.
Poster #3996:Decaup E. et al., Organoids and immune cells co-culture for evaluating the efficacy of Enfortumab Vedotin and pembrolizumab combination therapy.